Dang, Q., Li, L., Xie, H., He, D., Chen, J., Song, W., . . . Chang, C. (2015). Anti‐androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals. Mol Oncol.
Styl ChicagoDang, Qiang, et al. "Anti‐androgen Enzalutamide Enhances Prostate Cancer Neuroendocrine (NE) Differentiation Via Altering the Infiltrated Mast Cells → androgen Receptor (AR) → miRNA32 Signals." Mol Oncol 2015.
Citace podle MLADang, Qiang, et al. "Anti‐androgen Enzalutamide Enhances Prostate Cancer Neuroendocrine (NE) Differentiation Via Altering the Infiltrated Mast Cells → androgen Receptor (AR) → miRNA32 Signals." Mol Oncol 2015.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..